news
Researchers found that the SARS-CoV-2 infection activates the NF-κB pathway,…
2 October 2020 | By Hannah Balfour (Drug Target Review)
Researchers found that the SARS-CoV-2 infection activates the NF-κB pathway, driving unchecked inflammation that contributes to total organ failure in COVID-19 patients.